Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Risk of tuberculosis infection following tumour necrosis factor inhibitor treatment for chronic inflammatory arthritis – a systematic review and meta-analysis

Premila Kadamban and James Galloway
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.19-2-s117
Clin Med March 2019
Premila Kadamban
Academic Rheumatology, King's College, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Galloway
Academic Rheumatology, King's College, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Aims

Tumour necrosis factor-alpha inhibitors (TNFi) increase the risk of reactivation of latent tuberculosis (TB).

The objective of this review was to assess the risk of tuberculosis in patients receiving TNFi therapy and to compare the risks among the different anti-TNF agents.

Methods

We searched the electronic databases Medline and Embase using the combination of following terms biologic*, anti-TNF, etanercept, adalimumab, infliximab, golimumab and, certolizumab against ‘rheumatoid arthritis’ or RA, ‘psoriatic arthritis’ or PSA, ‘ankylosing spondylitis’ or AS, ‘inflammatory arthritis’ or IA with tuberculosis or TB.

Results

We came across a total of 34 relevant studies; of which 10 were included in the review after the application of STROBE checklist. The review included 41,127 subjects across three continents.

TNFi therapy significantly increases the risk of reactivation of TB and the reactivation risk is significantly influenced by the TB risk of background population. The relative risk of TB with the monoclonals is considerably higher compared with etanercept.

Conclusion

We recommend meticulous screening for latent TB and prophylaxis where necessary before commencing TNFi therapy. The screening tools and the prophylaxis should be decided based on the background TB risk and the prevalence of multidrug-resistant tuberculosis.

Conflict of interest statement

None

  • © Royal College of Physicians 2019. All rights reserved.
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Risk of tuberculosis infection following tumour necrosis factor inhibitor treatment for chronic inflammatory arthritis – a systematic review and meta-analysis
Premila Kadamban, James Galloway
Clinical Medicine Mar 2019, 19 (Suppl 2) 117; DOI: 10.7861/clinmedicine.19-2-s117

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Risk of tuberculosis infection following tumour necrosis factor inhibitor treatment for chronic inflammatory arthritis – a systematic review and meta-analysis
Premila Kadamban, James Galloway
Clinical Medicine Mar 2019, 19 (Suppl 2) 117; DOI: 10.7861/clinmedicine.19-2-s117
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Aims
    • Methods
    • Results
    • Conclusion
    • Conflict of interest statement
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Inaccessible back: frustration and misery of lonely patients
  • Methylation of somatostatin receptor 2 gene in neuroendocrine tumours as a predictor of tumour response to peptide receptor radionuclide therapy
  • Viral and other infections in community and primary hypothyroidism – cause or coincidence?
Show more Research and innovation

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians